These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lomefloxacin is an effective treatment of experimental bacterial keratitis. Kowalski RP; Romanowski EG; Yates KA; Gordon YJ Cornea; 2001 Apr; 20(3):306-8. PubMed ID: 11322421 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. Oliveira AD; D'Azevedo PA; Francisco W Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812 [TBL] [Abstract][Full Text] [Related]
6. [Lomefloxacin in treatment of infectious eye diseases]. Maĭchuk IuF; Vakhova ES; Kononenko LA Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer. Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial agents in infections of the central nervous system and eye. Papastamelos AG; Tunkel AR Infect Dis Clin North Am; 1995 Sep; 9(3):615-37. PubMed ID: 7490436 [TBL] [Abstract][Full Text] [Related]
9. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Scoper SV Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691 [TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolones in ophthalmology: indications and current use]. Chiquet C; Labetoulle M J Fr Ophtalmol; 2008 Oct; 31(8):803-8. PubMed ID: 19107048 [TBL] [Abstract][Full Text] [Related]
12. A Literature-Based Review and Analysis of the Pharmacodynamics of the Dose Frequency of Topical 0.3% Ciprofloxacin and 0.3% Ofloxacin in the Day-1 Treatment of Bacterial Keratitis. Pearce JG; Naunton M; Maddess T J Ocul Pharmacol Ther; 2023; 39(1):17-26. PubMed ID: 36454630 [No Abstract] [Full Text] [Related]
13. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. Hatano H; Inoue K; Shia S; Liping W Acta Ophthalmol (Copenh); 1993 Oct; 71(5):666-70. PubMed ID: 8109214 [TBL] [Abstract][Full Text] [Related]
14. Deposits of topical norfloxacin in the treatment of bacterial keratitis. Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239 [TBL] [Abstract][Full Text] [Related]
15. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Goldstein MH; Kowalski RP; Gordon YJ Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic considerations in the treatment of bacterial keratitis. Callegan MC; O'Callaghan RJ; Hill JM Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996 [TBL] [Abstract][Full Text] [Related]
20. Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis. Krustev SZ; Rusenova NV; Haritova AM Drug Dev Ind Pharm; 2014 Nov; 40(11):1459-62. PubMed ID: 23937580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]